Cuban Ready To Distribute Generic Drugs If CMS Agrees To March-In Alternative

Updated Story Mark Cuban, founder of the Mark Cuban Cost Plus Drug Company, tells Inside Health Policy he could take on the role of distributing the drugs should CMS back drug-pricing advocates’ proposed march-in alternative to license entities to make generic versions of expensive drugs like Xtandi. The advocates tell IHP the proposal they shared with CMS this week could be used beyond Xtandi for other expensive drugs developed in part with taxpayers’ funding. Cuban...